Overexpression of miR-99a, that is frequently down-regulated in RA and SLE, mitigated the development of experimental autoimmune encephalomyelitis (EAE) in mice through the inhibition of mammalian target of rapamycin (mTOR)-dependent glycolysis [231]. The gene discussed is MTOR; the disease is rheumatoid arthritis.